<code id='8ACD46E406'></code><style id='8ACD46E406'></style>
    • <acronym id='8ACD46E406'></acronym>
      <center id='8ACD46E406'><center id='8ACD46E406'><tfoot id='8ACD46E406'></tfoot></center><abbr id='8ACD46E406'><dir id='8ACD46E406'><tfoot id='8ACD46E406'></tfoot><noframes id='8ACD46E406'>

    • <optgroup id='8ACD46E406'><strike id='8ACD46E406'><sup id='8ACD46E406'></sup></strike><code id='8ACD46E406'></code></optgroup>
        1. <b id='8ACD46E406'><label id='8ACD46E406'><select id='8ACD46E406'><dt id='8ACD46E406'><span id='8ACD46E406'></span></dt></select></label></b><u id='8ACD46E406'></u>
          <i id='8ACD46E406'><strike id='8ACD46E406'><tt id='8ACD46E406'><pre id='8ACD46E406'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:Wikipedia    Page View:4368
          Frank Pallone -- health policy coverage from STAT
          Rep. Frank Pallone (D-N.J.) J. Scott Applewhite/AP

          WASHINGTON — A Democrat has signed on to a legislative package that would require health care transparency by law and enact modest payment reforms to pharmacy middlemen and hospitals, increasing its chances of passing the House of Representatives.

          Republicans conceded to a few tweaks to the legislation to ensure that transparency regulations for hospitals were at least equal to current regulations, which gained the endorsement of House Energy and Commerce Committee ranking member Frank Pallone (D-N.J.).

          advertisement

          Two other prominent Democrats on relevant committees didn’t sign on: Rep. Richard Neal (D-Mass.), who had voiced concerns about the bill’s lack of transparency provisions requiring disclosure of private equity ownership, and Rep. Bobby Scott (D-Va.).

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          FDA approval of Sarepta Duchenne genetic therapy gives me hope
          FDA approval of Sarepta Duchenne genetic therapy gives me hope

          Duchennemusculardystrophyhistopathology.Dr.EdwinP.Ewing,Jr./CDCWhenIwasdiagnosedwithDuchennemuscular

          read more
          Readout Newsletter: Novavax stock, FogPharma, Novo Nordisk
          Readout Newsletter: Novavax stock, FogPharma, Novo Nordisk

          Wanttostayontopofthescienceandpoliticsdrivingbiotechtoday? Signup togetourbiotechnewsletterinyourinb

          read more
          How one medical school became remarkably diverse
          How one medical school became remarkably diverse

          ThefirstclassattheUniversityofCalifornia,Davismedicalschool,in1972,waspredominantlywhiteandmale.Chri

          read more

          How state and local governments are sidelining science

          AhelicopterfliesaboveHoustonaweekafterHurricaneHarveyfloodedthearea.JustinSullivan/GettyImagesInlate